Loading...
Loading...
CryoCove Guide
Alpha-lipoic acid is the only antioxidant that works in both water and fat-soluble environments, recycles four other major antioxidants, acts as a mitochondrial cofactor, and crosses the blood-brain barrier. No other single compound does all of this. This guide covers the science, the forms, and the protocols.
4
Antioxidants it recycles
5
Blood sugar mechanisms
5
Major clinical trials
5
Synergy stacks
The Universal Antioxidant
A sulfur-containing compound produced in every cell, essential for mitochondrial energy production, and unique among antioxidants for its dual solubility.
Most antioxidants are limited in scope. Vitamin C only works in water-based environments (cytoplasm, blood plasma). Vitamin E only works in fat-based environments (cell membranes). Glutathione stays inside cells. CoQ10 is trapped in mitochondrial membranes. Alpha-lipoic acid is the only known antioxidant that works in all of these compartments — water, fat, intracellular, extracellular, mitochondrial, and even the central nervous system. Furthermore, it doesn’t just neutralize free radicals itself; it regenerates the other four antioxidants after they have been “spent.” This cascade effect means one molecule of ALA effectively multiplies the capacity of your entire antioxidant defense system. No other single compound has this breadth of action, which is why Lester Packer, PhD (UC Berkeley) coined the term “universal antioxidant” to describe it.
Forms Matter
Not all ALA supplements are created equal. The form you choose determines whether you get a biologically active compound or expensive filler.
| Property | R-ALA (Natural) | S-ALA (Synthetic) |
|---|---|---|
| Natural occurrence | Produced by mitochondria in every human cell | Does not exist in nature; synthetic byproduct only |
| Biological activity | Fully bioactive — recognized by enzymes and receptors | Minimal to no biological activity in most pathways |
| Absorption rate | Rapidly absorbed; higher peak blood levels | Slower absorption; may interfere with R-ALA uptake |
| Mitochondrial cofactor | Yes — essential cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase | Cannot function as a mitochondrial cofactor |
| AMPK activation | Potent AMPK activator — drives GLUT4 translocation | Weak or absent AMPK activation |
| Nrf2 activation | Strong Nrf2 activator — upregulates phase II detox enzymes and glutathione synthesis | Minimal Nrf2 activation |
| Antioxidant recycling | Efficiently recycles vitamins C, E, glutathione, and CoQ10 | Limited antioxidant recycling capacity |
| Cost | Higher cost per capsule (worth it for efficacy) | Cheaper — found in racemic (50/50) ALA supplements |
Natural occurrence
R-ALA
Produced by mitochondria in every human cell
S-ALA
Does not exist in nature; synthetic byproduct only
Biological activity
R-ALA
Fully bioactive — recognized by enzymes and receptors
S-ALA
Minimal to no biological activity in most pathways
Absorption rate
R-ALA
Rapidly absorbed; higher peak blood levels
S-ALA
Slower absorption; may interfere with R-ALA uptake
Mitochondrial cofactor
R-ALA
Yes — essential cofactor for pyruvate dehydrogenase and alpha-ketoglutarate dehydrogenase
S-ALA
Cannot function as a mitochondrial cofactor
AMPK activation
R-ALA
Potent AMPK activator — drives GLUT4 translocation
S-ALA
Weak or absent AMPK activation
Nrf2 activation
R-ALA
Strong Nrf2 activator — upregulates phase II detox enzymes and glutathione synthesis
S-ALA
Minimal Nrf2 activation
Antioxidant recycling
R-ALA
Efficiently recycles vitamins C, E, glutathione, and CoQ10
S-ALA
Limited antioxidant recycling capacity
Cost
R-ALA
Higher cost per capsule (worth it for efficacy)
S-ALA
Cheaper — found in racemic (50/50) ALA supplements
Sodium R-alpha-lipoic acid
Pure R-ALA has a stability problem: it polymerizes (clumps) at room temperature, which reduces potency and absorption. Na-R-ALA solves this by bonding R-ALA to a sodium molecule, creating a heat-stable, water-soluble form that achieves 40-50% higher peak blood levels than unstabilized R-ALA.
10-20 min
Peak absorption (empty stomach)
40-50%
Higher bioavailability vs free R-ALA
100%
Heat and shelf stable
The Cascade Effect
ALA does not just neutralize free radicals on its own — it regenerates four other major antioxidants, creating a self-renewing defense system.
Water-soluble
Mechanism: ALA donates electrons to oxidized vitamin C (dehydroascorbic acid), regenerating it to active ascorbic acid
Significance: Extends vitamin C lifespan 5-10x; vitamin C then regenerates vitamin E
Fat-soluble
Mechanism: ALA regenerates vitamin E indirectly (via vitamin C) and directly by reducing tocopheroxyl radical back to alpha-tocopherol
Significance: Protects cell membranes from lipid peroxidation chain reactions
Water-soluble
Mechanism: ALA reduces oxidized glutathione (GSSG) to reduced glutathione (GSH) and upregulates de novo glutathione synthesis via Nrf2
Significance: Glutathione is the master intracellular antioxidant; ALA raises GSH levels 30-70% in studies
Fat-soluble
Mechanism: ALA regenerates oxidized CoQ10 (ubiquinone) back to its active reduced form (ubiquinol)
Significance: CoQ10 is essential for mitochondrial electron transport chain — regeneration maintains cellular energy production
Free Radical Attack
A reactive oxygen species (ROS) attacks a cell membrane, threatening lipid peroxidation
Vitamin E Intercepts
Vitamin E neutralizes the ROS in the membrane but becomes oxidized (tocopheroxyl radical)
Vitamin C Regenerates E
Vitamin C donates an electron to regenerate vitamin E but becomes oxidized itself
ALA Regenerates C, E & GSH
ALA (as DHLA) regenerates vitamin C, glutathione, and CoQ10 — restarting the entire cascade
Metabolic Health
ALA is one of the most studied natural compounds for glucose management. It works through at least five distinct mechanisms — more than most pharmaceutical interventions.
ALA activates AMPK, which triggers GLUT4 glucose transporters to migrate to the cell surface. This allows glucose to enter muscle and fat cells independent of insulin — mimicking insulin's primary action without requiring insulin signaling.
ALA reduces oxidative stress that damages insulin receptor substrate (IRS-1) and PI3K signaling. By protecting these signaling molecules, ALA restores the cell's ability to respond to insulin's signal, improving whole-body insulin sensitivity.
Pancreatic beta cells are highly susceptible to oxidative damage because they have low antioxidant defenses. ALA protects beta cells from glucotoxicity and lipotoxicity, preserving insulin-producing capacity over time.
ALA suppresses gluconeogenesis (glucose production by the liver) through AMPK activation. This reduces fasting blood glucose by decreasing the liver's contribution to circulating glucose levels.
ALA inhibits the formation of advanced glycation end products (AGEs) — sugar-protein complexes that damage tissues and activate inflammatory RAGE receptors. This protects blood vessels, kidneys, nerves, and eyes from hyperglycemia-related damage.
Want This Personalized?
This guide gives you the science. A CryoCove coach gives you the personalization — the right dose, timing, and integration with your other 8 pillars.
Nerve Health
ALA has been used as a prescription treatment for diabetic neuropathy in Germany for over 60 years. The clinical trial evidence is extensive and compelling.
| Study | Dose | Outcome |
|---|---|---|
| SYDNEY Trial | 600 mg IV ALA daily for 3 weeks | Significant improvement in Total Symptom Score (TSS) including pain, burning, paresthesia, and numbness. Benefits observed within 1 week. |
| ALADIN I | 100, 600, or 1200 mg IV ALA daily for 3 weeks | 600 mg dose optimal — significant TSS reduction vs placebo. 1200 mg showed no additional benefit but more side effects. 100 mg ineffective. |
| ALADIN III | 600 mg IV for 3 weeks, then 1800 mg oral for 6 months | IV phase showed significant neuropathy improvement. Oral phase showed trends toward improvement in specific endpoints but did not reach significance for primary endpoint. |
| NATHAN-1 | 600 mg oral ALA daily for 4 years | Significant improvement in composite neuropathy score. First long-term trial proving disease-modifying effect of oral ALA on diabetic neuropathy progression. |
| Meta-analysis (Mijnhout et al.) | 600 mg IV or oral ALA | Confirmed 600 mg as the optimal dose for diabetic neuropathy. Concluded ALA is safe and effective for symptomatic polyneuropathy treatment. |
SYDNEY Trial
181 patients, randomized, double-blind, placebo-controlled
Dose
600 mg IV ALA daily for 3 weeks
Significant improvement in Total Symptom Score (TSS) including pain, burning, paresthesia, and numbness. Benefits observed within 1 week.
ALADIN I
328 type 2 diabetics with symptomatic neuropathy, randomized
Dose
100, 600, or 1200 mg IV ALA daily for 3 weeks
600 mg dose optimal — significant TSS reduction vs placebo. 1200 mg showed no additional benefit but more side effects. 100 mg ineffective.
ALADIN III
509 patients, randomized, placebo-controlled
Dose
600 mg IV for 3 weeks, then 1800 mg oral for 6 months
IV phase showed significant neuropathy improvement. Oral phase showed trends toward improvement in specific endpoints but did not reach significance for primary endpoint.
NATHAN-1
460 patients, randomized, double-blind, 4-year trial
Dose
600 mg oral ALA daily for 4 years
Significant improvement in composite neuropathy score. First long-term trial proving disease-modifying effect of oral ALA on diabetic neuropathy progression.
Meta-analysis (Mijnhout et al.)
Systematic review of RCTs
Dose
600 mg IV or oral ALA
Confirmed 600 mg as the optimal dose for diabetic neuropathy. Concluded ALA is safe and effective for symptomatic polyneuropathy treatment.
Based on the composite Total Symptom Score (TSS) used across clinical trials, ALA at 600 mg/day improves the following neuropathy symptoms:
Detoxification
ALA's sulfur atoms and dual solubility make it a uniquely effective detoxification agent — but proper protocols are essential.
Nuclear factor erythroid 2-related factor 2
Nrf2 is a transcription factor that acts as the master regulator of cellular defense. Under normal conditions, Nrf2 is kept inactive in the cytoplasm by Keap1. ALA modifies Keap1’s cysteine residues, releasing Nrf2 to enter the nucleus and activate the antioxidant response element (ARE) — turning on hundreds of protective genes simultaneously.
Phase II Detox Enzymes
Glutathione S-transferase, UDP-glucuronosyltransferase, NAD(P)H quinone oxidoreductase — enzymes that conjugate and excrete toxins
Glutathione Synthesis
Upregulates gamma-glutamylcysteine ligase (GCL) — the rate-limiting enzyme in glutathione production — increasing cellular GSH levels
Anti-Inflammatory Genes
Suppresses NF-kB activation and reduces inflammatory cytokine production (IL-6, TNF-alpha). Nrf2 and NF-kB have an inverse relationship
ALA has emerged as a compelling anti-aging compound for skin, working through multiple mechanisms that address the root causes of skin aging rather than just surface symptoms.
AGE Inhibition
ALA inhibits glycation — the binding of sugar to collagen and elastin proteins that causes cross-linking, loss of elasticity, and wrinkle formation. Glycation is one of the primary mechanisms of skin aging.
Photoprotection
ALA reduces UV-induced oxidative damage in skin cells. When applied topically or taken orally, it reduces erythema (sunburn) response and protects against UV-induced NF-kB activation and MMP expression.
Collagen Preservation
By inhibiting MMP (matrix metalloproteinase) enzymes — which break down collagen — and reducing oxidative damage to collagen fibers, ALA helps maintain skin structural integrity over time.
Pore Reduction
Topical ALA is one of the few compounds shown to visibly reduce pore size. Dr. Nicholas Perricone popularized ALA in dermatology, demonstrating its ability to improve skin texture, reduce fine lines, and decrease pore appearance.
Practical Application
The optimal dose depends on what you are trying to achieve. Here are evidence-based protocols for the most common use cases.
100-300 mg R-ALA daily
Timing
Morning, empty stomach, 30 min before breakfast
Duration
Ongoing daily use
Entry-level dose for broad antioxidant protection, glutathione support, and mitochondrial function. Low risk of side effects at this range. Suitable for most adults.
300-600 mg R-ALA daily (split doses)
Timing
Split into 2-3 doses, each 30 min before meals
Duration
Ongoing; retest glucose markers at 4 and 12 weeks
Pre-meal timing blunts postprandial glucose spikes. 600 mg is the most studied dose for glucose management. Monitor blood sugar if on diabetic medications. Add 5,000 mcg biotin at a separate time of day.
600 mg R-ALA daily
Timing
Single dose on empty stomach or split 300 mg 2x/day
Duration
Minimum 5 weeks for initial assessment; 3-6 months for full benefit
Based on ALADIN and SYDNEY trial protocols. Some practitioners start with IV ALA for 2-3 weeks, then transition to oral. Na-R-ALA preferred for superior absorption. Expect gradual improvement in tingling, burning, and numbness.
300-600 mg R-ALA daily
Timing
Morning, empty stomach
Duration
8-12 week cycles or ongoing
ALA protects hepatocytes via Nrf2 activation and glutathione elevation. Used clinically in mushroom poisoning (Amanita phalloides) as emergency liver protection. For general liver support, combine with milk thistle (silymarin) and NAC for synergistic hepatoprotection.
12.5-50 mg ALA every 3 hours (around the clock)
Timing
Every 3 hours including during sleep — do not miss doses
Duration
3 days on, minimum 4 days off; repeated cycles over months
ADVANCED — do not attempt without understanding the full Cutler protocol. Frequent low doses maintain stable blood levels to prevent metal redistribution. Skipping doses causes ALA to mobilize metals without excreting them, potentially worsening symptoms. Must be combined with DMSA or DMPS for initial rounds. Work with an experienced practitioner.
| Form | Typical Dose | Frequency | Best For |
|---|---|---|---|
| R-ALA | 100-300 mg | 1-2x daily | General antioxidant, daily maintenance |
| Na-R-ALA | 150-300 mg | 1-2x daily | Better absorption, blood sugar, neuropathy |
| Racemic ALA (R+S) | 300-600 mg | 1-2x daily | Budget option (only 50% active) |
| IV ALA | 600 mg | Daily for 2-3 weeks | Acute neuropathy (clinical setting only) |
CryoCove Synergies
ALA amplifies the effects of other supplements and protocols. These stacks combine ALA with complementary compounds for targeted outcomes.
R-ALA (300 mg) + NAC (600 mg) + Vitamin C (1,000 mg) + Vitamin E (200 IU)
ALA recycles all three other antioxidants, creating an amplification loop. NAC provides cysteine for glutathione synthesis, which ALA then helps maintain in its reduced (active) form. This stack maximizes the antioxidant recycling cascade.
Related GuideR-ALA (600 mg) + Berberine (500 mg) + Chromium (200 mcg) + Magnesium (400 mg)
ALA and berberine both activate AMPK through different mechanisms — the combination is synergistic for insulin sensitivity and GLUT4 translocation. Chromium enhances insulin receptor function. Magnesium is a cofactor for 600+ enzymatic reactions including glucose metabolism.
Related GuideR-ALA (300 mg) + CoQ10 (200 mg) + PQQ (20 mg) + B-complex
ALA is a mitochondrial cofactor (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase) and regenerates CoQ10 in the electron transport chain. PQQ stimulates mitochondrial biogenesis. B vitamins are essential cofactors for the Krebs cycle. This stack optimizes cellular energy production.
Related GuideR-ALA (300 mg) + NMN or NR (500 mg) + Resveratrol (500 mg) + Quercetin (500 mg)
ALA reduces AGE formation (a hallmark of aging) and activates Nrf2 for phase II detox. NMN/NR supports NAD+ levels for sirtuin activation. Resveratrol activates SIRT1. Quercetin acts as a senolytic, clearing senescent cells. This stack targets multiple aging pathways simultaneously.
Related GuideR-ALA (600 mg) + Acetyl-L-Carnitine (1,000 mg) + Omega-3 (2 g EPA+DHA) + Lion's Mane (1,000 mg)
ALA and acetyl-L-carnitine are one of the most studied neuroprotective combinations — together they reverse age-related mitochondrial decay in neurons (Ames et al. research). ALA crosses the blood-brain barrier to chelate metals and reduce neuroinflammation. Omega-3s provide structural membrane support. Lion's mane stimulates NGF production.
Related GuideBeyond its antioxidant role, ALA is an essential cofactor for two critical mitochondrial enzyme complexes. Without ALA, the Krebs cycle cannot function and ATP production halts.
Pyruvate Dehydrogenase Complex (PDC)
Converts pyruvate to acetyl-CoA — the gateway reaction linking glycolysis to the Krebs cycle. Without this step, carbohydrates cannot be fully metabolized for energy. ALA (bound as lipoamide) is an essential cofactor for this reaction.
Alpha-Ketoglutarate Dehydrogenase Complex
Catalyzes a key step in the Krebs cycle (alpha-ketoglutarate to succinyl-CoA). This is often the rate-limiting step of the entire cycle. ALA is again an essential cofactor. Supplemental ALA may support optimal flux through this reaction, particularly in aging mitochondria.
Safety Profile
ALA has a strong safety profile at standard doses. However, there are important interactions and considerations to be aware of, especially at higher doses.
Severity: Moderate
ALA competes with biotin for the SMVT transporter. At doses above 300 mg/day, biotin absorption can be significantly reduced over time. Symptoms include hair loss, brittle nails, skin issues, and paradoxically, blood sugar instability (biotin is a gluconeogenesis cofactor).
Mitigation: Supplement with 5,000-10,000 mcg biotin daily, taken at least 2 hours apart from ALA doses.
Severity: Moderate (with medications)
ALA lowers blood sugar through insulin-independent mechanisms (GLUT4 translocation). When combined with diabetes medications (metformin, sulfonylureas, insulin), additive blood sugar lowering can cause hypoglycemia. Healthy individuals at normal doses are at minimal risk.
Mitigation: Monitor blood glucose when starting ALA, especially if on diabetes medications. Start at 300 mg/day and titrate up. Work with your prescribing physician on medication dose adjustments.
Severity: High (if misused)
ALA chelates heavy metals and crosses the blood-brain barrier. Infrequent or high single doses can mobilize metals (especially mercury) without fully excreting them, potentially redistributing them to sensitive organs including the brain.
Mitigation: For general supplementation (300-600 mg/day), this is not a significant concern. For intentional chelation, follow the Cutler protocol strictly (low dose every 3 hours around the clock). Never take large single doses if you have dental amalgams or known mercury exposure.
Severity: Low
Some people experience nausea, heartburn, or stomach upset when taking ALA on an empty stomach, particularly at higher doses (600+ mg). This is usually dose-dependent and transient.
Mitigation: Start with a lower dose (100-200 mg) and titrate up. Take with a small amount of food if necessary, accepting slightly reduced absorption. Na-R-ALA tends to be better tolerated than free-form R-ALA.
Severity: Low-Moderate
ALA may reduce conversion of T4 to T3 (the active thyroid hormone) at high doses. This is relevant for people with hypothyroidism or those taking levothyroxine (T4 replacement).
Mitigation: If you have hypothyroidism, monitor thyroid function when starting ALA. Take ALA at least 4 hours apart from thyroid medication. Some practitioners add selenium (200 mcg) to support T4-to-T3 conversion.
Severity: Rare
Rare reports of skin rash, itching, or allergic reaction. More common with racemic (R+S) ALA than pure R-ALA, possibly due to the S-enantiomer or manufacturing impurities.
Mitigation: Discontinue if rash appears. Switch to a different brand or form (Na-R-ALA from a reputable manufacturer). True ALA allergy is extremely rare.
Disclaimer: Alpha-lipoic acid supplements are not a replacement for medical treatment. Always consult your healthcare provider before starting ALA supplementation, especially if you take diabetes medications, thyroid medications, or have known heavy metal exposure. The information in this guide is educational, not prescriptive. See our full disclaimer.
FAQ
Antioxidant
The master antioxidant that ALA recycles. How to raise glutathione levels through precursors, lifestyle, and supplementation.
Energy
ALA is a mitochondrial cofactor. Learn how to optimize cellular energy production and mitochondrial health.
Metabolic
Blood sugar regulation, insulin sensitivity, and the metabolic health stack that includes ALA.
This guide gives you the science. A CryoCove coach gives you the personalization — which forms to use, how to stack ALA with your existing supplements, blood sugar monitoring strategy, and ongoing protocol adjustments based on your biomarkers.